Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Integrative therapies for cancer symptom relief

Official title: Examining the Impact of an Integrative Oncology Program on Patient Symptoms and Quality of Life: a Prospective Pragmatic Registry Protocol Study

Run by Shaare Zedek Medical Center · NCT04940780 · Data updated 2026-11-12

This study is testing whether acupuncture or touch therapies can help relieve symptoms and improve the quality of life for cancer patients undergoing treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment750 (estimated)
SponsorShaare Zedek Medical Center
Academic / other
Locations1 site (Jerusalem)
StatusRecruiting
StartedNovember 1, 2021
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedApril 29, 2026
Trial IDNCT04940780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are currently undergoing active oncology treatment.

Probably not a fit

Patients who are not interested in attending all eight CIM treatment sessions or do not meet the eligibility criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of complementary and integrative medicine (CIM) on patients experiencing symptoms related to cancer and its treatment. A total of 750 patients undergoing active oncology treatment will receive a consultation with an integrative oncologist followed by eight sessions of either acupuncture or touch therapies. The aim is to assess the impact of these therapies on symptom burden, quality of life, and overall function. The study will provide valuable insights into the role of CIM in supportive cancer care.

Why it matters

Potential benefit: If successful, this study could significantly improve the quality of life for cancer patients by alleviating their symptoms through integrative therapies.

How similar studies have gone: Previous studies have shown positive outcomes with similar integrative approaches in oncology, indicating a promising avenue for symptom management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age ≥ 18 years
* undergoing active oncology treatment
* fully understand the study plan
* agree to sign the study informed consent form.

Exclusion Criteria:

* not fulfilling all of the study criteria
* not interested in attending all 8 weekly CIM treatments sessions

Where it's running

  • Institute of Oncology, Shaare Zedek Medical Center
    Jerusalem, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.